おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Replay
company
About
Replay is a genome writing company reprogramming biology by writing and delivering big DNA.
- 11 - 50
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $55M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$55M
Replay has raised a total of
$55M
in funding over 2 rounds. Their latest funding was raised on
Jul 25, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 25, 2022 | Seed | $55M | 1 |
Kohlberg Kravis Roberts
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Replay is funded by 1 investors.
Kohlberg Kravis Roberts
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kohlberg Kravis Roberts
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
